No genomic aberrations in langerhans cell histiocytosis as assessed by diverse molecular technologies

Genes Chromosomes and Cancer

Volumn 48, Issue 3, 2009, Pages 239-249

  Da Costa, Cristiana E T ^a   Szuhai, Karoly ^a   Van Eijk, Ronald ^a   Hoogeboom, Manja ^a   Sciot, Raphael ^b   Mertens, Fredrik ^c   Björgvinsdóttir, Helga ^c   Debiec Rychter, Maria ^b   De Krijger, Ronald R ^d   Hogendoorn, Pancras C W ^a   Maarten Egeler, R ^a   Annels, Nicola E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53; T6 ANTIGEN;

ADULT; ARTICLE; CHILD; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA CONTENT; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; GENE SEQUENCE; GENE TRANSLOCATION; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LANGERHANS CELL; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD1; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MUTATIONAL ANALYSIS; FEMALE; FLOW CYTOMETRY; GENES, P53; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; KARYOTYPING; LANGERHANS CELLS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLOIDIES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 62449241914     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20634     Document Type: Article

References (32)

1. Arico M, Nichols K, Whitlock JA, Arceci R, Haupt R, Mittler U, Kuhne T, Lombardi A, Ishii E, Egeler RM, Danesino C. 1999.
2. Familial clustering of Langerhans cell histiocytosis. Br J Haema-tol 107:883-888.
3. Bank MI, Rengtved P, Carstensen H, Petersen BL. 2003. Langer-hans cell histiocytosis: an evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies. APMIS 111:300-308.
4. Bechan GI, Meeker AK, de Marzo AM, Racke F, Jaffe R, Sugar E, Arceci R. 2007. Telomere length shortening in Langerhans cell histiocytosis. Br J Haematol 140:420-428. Betts DR, Leibundgut KE, Feldges A, Pluss HJ, Niggli FK. 1998.
5. Cytogenetic abnormalities in Langerhans cell histiocytosis. Br J Cancer 77:552-555.
6. Chikwava KR, Hunt JL, Mantha GS, Murphy JE, Jaffe R. 2007. Analysis of loss of heterozygosity in single-system and multisystem Langerhans' cell histiocytosis. Pediatr Dev Pathol 10:18-24.
7. Corver WE, Ter Haar NT, Dreef EJ, Miranda N, Prins FA, Jorda-nova ES, Cornelisse CJ, Fleuren GJ. 2005. High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues. J Pathol 206:233-241.
8. Coury F, Annels N, Rivollier A, Olsson S, Santoro A, Speziani C, Azocar O, Flacher M, Djebali S, Tebib J, Brytting M, Egeler RM, Rabourdin-Combe C, Henter JI, Arico M, Delprat C. 2008. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 14:81-87.
9. Da Costa CE, Egeler RM, Hoogeboom M, Szuhai K, Forsyth RG, Niesters M, de Krijger RR, Tazi A, Hogendoorn PCW, Annels NE. 2007. Differences in telomerase expression by the CD1a+cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease. J Pathol 212:188-197.
10. Egeler RM, D'Angio GJ. 1995. Langerhans cell histiocytosis. J Pediatr 127:1-11.
11. Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broad-bent V, Rey G, McClain KL, Janka-Schaub G, Egeler RM. 2004. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 42:438-444.
12. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatys-zek MA, Shay JW, Ishioka A, Yamakido M. 1995. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155:3711-3715.
13. ISCN. 2005. An International System for Human Cytogenetic Nomenclature. Shaffer LG, Tommerup N, editors. Basel: Karger.
14. Huang J, Wei W, Zhang J, Liu G, Bignell GR, Stratton MR, Futreal PA, Wooster R, Jones KW, Shapero MH. 2004. Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum Genomics 1:287-299.
15. Knijnenburg J, Szuhai K, Giltay J, Molenaar L, Sloos W, Poot M, Tanke HJ, Rosenberg C. 2005. Insights from genomic microar-rays into structural chromosome rearrangements. Am J Med Genet A 132:36-40.
16. Knijnenburg J, van der Burg M, Tanke HJ, Szuhai K. 2007. Optimized amplification and fluorescent labeling of small cell samples for genomic array-CGH. Cytometry 71A:585-591.
17. Liu L, Lai S, Andrews LG, Tollefsbol TO. 2004. Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 340:1-10.
18. Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitel-man F. 1988. Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Hum Genet 79:203-208.
19. McLelland J, Newton J, Malone M, Camplejohn RS, Chu AC. 1989. A flow cytometric study of Langerhans cell histiocytosis. Br J Dermatol 120:485-491.
20. Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H. 2000. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Klin Padiatr 212:139-144.
21. Murakami I, Gogusev J, Fournet JC, Glorion C, Jaubert F. 2002. Detection of molecular cytogenetic aberrations in langerhans cell histiocytosis of bone. Hum Pathol 33:555-560.
22. Nezelof C, Basset F. 2004. An hypothesis Langerhans cell histiocytosis: The failure of the immune system to switch from an innate to an adaptive mode. Pediatr Blood Cancer 42:398-400.
23. Ornvold K, Carstensen H, Larsen JK, Christensen IJ, Ralfkiaer E. 1990. Flow cytometric DNA analysis of lesions from 18 children with langerhans cell histiocytosis (histiocytosis x). Am J Pathol 136:1301-1307.
24. Oostlander AE, Meijer GA, Ylstra B. 2004. Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet 66:488-495.
25. Pokrovskaja K, Okan I, Kashuba E, Lowbeer M, Klein G, Szekely L. 1990. Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis. J Gen Virol 80:987-995.
26. Rabkin MS, Wittwer CT, Kjeldsberg CR, Piepkorn MW. 1988. Flow-cytometric DNA content of histiocytosis X (Langerhans cell histiocytosis). Am J Pathol 131:283-289.
27. Schouten B, Egeler RM, Leenen PJ, Taminiau AH, van den Broek LJ, Hogendoorn PC. 2002. Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J Pediatr Hematol Oncol 24:727-732.
28. Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K, Swede H, McCann S, Hall P, Shields PG, Freu-denheim JL. 2006. p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomark Prev 15:80-85.
29. Weintraub M, Bhatia KG, Chandra RS, Magrath IT, Ladisch S. 1998. p53 expression in Langerhans cell histiocytosis. J Pediatr Hematol Oncol 20:12-17.
30. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG. 1994. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease. N Engl J Med 331:154-160.
31. Woods CG, Cox J, Springell K, Hampshire DJ, Mohamed MD, McKibbin M, Stern R, Raymond FL, Sandford R, Sharif SM, Karbani G, Ahmed M, Bond J, Clayton D, Inglehearn CF. 2006. Quantification of homozygosity in consanguineous individuals with autosomal recessive disease. Am J Hum Genet 78:889-896.
32. Yu RC, Chu C, Buluwela L, Chu AC. 1994. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 343:767-768.